By Samuel S. Thatcher, M.D.
Polycystic Ovarian Syndrome (PCOS) is a complex hormonal disturbance affecting the entire body with numerous implications for a woman's long-term health and quality of life. PCOS is the most common hormonal disturbance of pre-menopausal women and is a leading cause of infertility, but infertility is not the only problem PCOS creates. Common symptoms unrelated to fertility include obesity, abnormal hair growth, skin problems, and abnormal menstrual periods. Additionally, we now know that PCOS has far longer-term health consequences. Women with PCOS have at least 7 times the risk of heart attack and heart disease than other women, are at risk for hypertension, and by the age of 40, 40% of PCOS patients develop Type 2 diabetes.
Because often individual symptoms of the syndrome have been presented one at a time to a variety of professionals (gynecologists, dermatologists, internists, hair removal specialists) PCOS has been in the closet for far too long, underestimated both in prevalence and importance. The disease is beginning to receive the attention it deserves through interest and research. Even popular women's magazines including, Cosmopolitan, Elle, Redbook, and Ladies Home Journal have published articles on PCOS. There are hundreds of visitors each day to sites on the internet dedicated to PCOS. Yet there has been no comprehensive source of information available to PCOS sufferers… until now. Dr. Thatcher’s book is an exciting first in this field!
Table of Contents
PCOS: The Silent Epidemic is available in hardcover, ISBN 0-944934-25-0, $24.95.
Pat Johnston, Publisher
Perspectives Press: The Infertility and Adoption Publisher
PO Box 90318, Indianapolis, IN 46290-0318 USA *phone (317)872-3055
visit our website at http://www.perspectivespress.com
S1E4: Dr. Kristina Adams-Waldorf: Pandemics, pathogens and perseverance
July 16th 2020This episode of Pap Talk by Contemporary OB/GYN features an interview with Dr. Kristina Adams-Waldorf, Professor in the Department of Obstetrics and Gynecology and Adjunct Professor in Global Health at the University of Washington (UW) School of Medicine in Seattle.
Listen
Similar delivery times between misoprostol dosages among obese patients reported
May 29th 2024A recent study found that obese patients undergoing induction of labor experienced similar delivery times regardless of whether they received 50 μg or 25 μg of vaginal misoprostol, though multiparous patients showed faster delivery with the higher dosage.
Read More